PP_1170x120_10-25-21

Johnson and Johnson vaccine

FDA and CDC call for pause of J&J vaccine over blood clot cases

FDA and CDC call for pause of J&J vaccine over blood clot cases

WASHINGTON — On Tuesday both the Food and Drug Administration and Centers for Disease Control and Prevention  are recommending a “pause” in the administration of Johnson & Johnson’s single-dose COVID-19 vaccine to review blood clot cases. The agencies announced in a statement that the CDC will convene a meeting of the Advisory Committee on Immunization Practices